NCT07649915

Brief Summary

The GRIP (Gordian Robotic Integrated Port Closure) Study is a prospective, single-arm feasibility study evaluating the use of the TroClose™ 1200 device for closure of da Vinci® 12 mm robotic assistant port sites following robotic-assisted surgical procedures. TroClose™ 1200 is an FDA-cleared medical device designed to facilitate fascial closure of laparoscopic and robotic access ports. The device deploys anchors and suture at the beginning of the procedure, allowing closure to be completed at the end of surgery without the need for additional needle passage or specialized closure instruments. The purpose of this study is to assess the safety, feasibility, procedural performance, and clinical outcomes associated with use of the device in patients undergoing robotic-assisted surgery. Study assessments will include successful port-site closure, device-related adverse events, post-operative complications, and short-term follow-up evaluations. Approximately 26 adult participants undergoing robotic-assisted surgical procedures at Allegheny Health Network will be enrolled.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
5mo left

Started Jun 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress20%
Jun 2026Dec 2026

First Submitted

Initial submission to the registry

June 5, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 16, 2026

Completed
14 days until next milestone

Study Start

First participant enrolled

June 30, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

June 16, 2026

Status Verified

June 1, 2026

Enrollment Period

5 months

First QC Date

June 5, 2026

Last Update Submit

June 11, 2026

Conditions

Keywords

Robotic SurgeryPort Site ClosureIntegrated Robotic Closure

Outcome Measures

Primary Outcomes (2)

  • Technical Success; To determine the ability of the TroClose™ 1200 to achieve fascial closure when used with a 12mm da Vinci® robotic assistant port during robotic surgery

    Measured by confirmation of fascial closure by digital (finger) palpation - Measured as either closed or not closed.

    30 days

  • Technical Success; To determine the ability of the TroClose™ 1200 to achieve fascial closure when used with a 12mm da Vinci® robotic assistant port during robotic surgery

    Measured by confirmation of fascial closure by visual inspection - Measured as either closed or not closed.

    30 days

Secondary Outcomes (1)

  • Safety; Freedom from peri operative serious adverse events

    30 days

Study Arms (1)

Interventional - TroClose1200 with DaVinci Robot

EXPERIMENTAL

This intervention will assess affective fascial closure utilizing the TroClose1200 device in DaVinci Robotic procedures.

Device: Fascial closure device

Interventions

* TroClose™ is inserted at the start of the procedure and anchors/sutures are deployed. * TroClose™ trocar is removed and replaced with a da Vinci® 12 mm port. * Sutures are tied at the end of the case.

Interventional - TroClose1200 with DaVinci Robot

Eligibility Criteria

Age18 Years - 95 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Males or female patients age 18 to 95 years old
  • Scheduled to undergo an elective, clinically indicated robotic surgery with a da Vinci® 12 mm assistant port
  • Trocar site is appropriate for TroClose™ per Investigator/Surgeon discretion
  • Subject is able and willing to sign a written informed consent form

You may not qualify if:

  • Scheduled to undergo emergency surgery
  • Weight under 45kg (99.2 pounds)
  • Infection at port site
  • Prior surgical mesh at intended incision location
  • Surgeon-determined contraindication for use of the TroClose™ 1200
  • Inability to provide written, informed consent
  • Known allergy to PGA (Polyglycolic Acid)
  • PLA (Polylactic Acid).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AHN Allegheny General Hospital

Pittsburgh, Pennsylvania, 15212, United States

Location

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 5, 2026

First Posted

June 16, 2026

Study Start

June 30, 2026

Primary Completion (Estimated)

November 30, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

June 16, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

There is no plan to share data with other research groups now or in the future

Locations